Skip to content
Screener

Alkermes ALKS Other Non-Current Assets

Other Non-Current Assets at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$6.38B+7.4%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$94.7M-18.7%
Indivior Pharmaceuticals, Inc. logo
Indivior Pharmaceuticals, Inc.INDV
$26M-33.3%
Harmony Biosciences Holdings, Inc. logo
Harmony Biosciences Holdings, Inc.HRMY
$26.43M+345%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$116.54M-11.8%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$20.1M-8.6%

Segments

By geography

See full
US$499.04M
IE$82.29M

Other financials

Income statement

See full
Revenue$496.0M+27.0%
Gross profit$397.9M+16.6%
Operating income$18.4M-80.3%
Net income$501.0K-99.4%
EPS (diluted)$0.00-100%

Balance sheet

See full
Cash & equivalents$511.5M-1.9%
Total debt$1.6B+2,064%
Total equity$1.8B+11.3%
Total assets$4.4B+95.0%

Cash flow

See full
Operating cash flow-$165.7M-268%
CapEx$8.1M-37.4%
Free cash flow-$169.8M-291%

Valuation

See full
Market cap$8.32B+89.9%
Enterprise value$9.38B+139%
P/E125.9×+113×
P/S+2.1×

Profitability

See full
Gross margin84.6%-0.6pp
Operating margin7%-17.8pp
Net margin4%-19.2pp
FCF margin14.2%-17.6pp

Returns & leverage

See full
Return on equity3.9%-20.1pp
Debt / equity0.9×+0.8×
Current ratio2.3×-0.9×

Where this comes from

Reported directly by Alkermes in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The source filing: Alkermes’s 10-Q, filed July 28, 2026.

Filed
Jul 28, 2026, 9:22 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-319022
Line itemJune 30, 2026December 31, 2025
INTANGIBLE ASSETS, NET1,761,456815
GOODWILL594,27383,027
DEFERRED TAX ASSETS123,041125,815
OTHER ASSETS62,00049,099
TOTAL ASSETS$4,393,125$2,486,993
LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accounts payable and accrued expenses$332,469$289,565

Item 1. Condensed Consolidated Financial Statements:

FAQ

What is Alkermes's other non-current assets?
Alkermes (ALKS) reported other non-current assets of $62M in Q2 2026.
How has Alkermes's other non-current assets changed year-over-year?
Alkermes's other non-current assets increased by 211.4% year-over-year, from $19.91M to $62M.
What is the long-term trend for Alkermes's other non-current assets?
Over 5 years (2020 to 2025), Alkermes's other non-current assets has grown at a 23.2% compound annual growth rate (CAGR), from $17.32M to $49.1M.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.

Ask your AI about Alkermes's other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude